Filing Details
- Accession Number:
- 0001203311-21-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-13 21:39:53
- Reporting Period:
- 2021-08-13
- Accepted Time:
- 2021-08-13 21:39:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741836 | D Roger Dansey | 21823 30Th Drive Se Bothell WA 98021 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-13 | 9,900 | $156.58 | 74,535 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-13 | 100 | $157.25 | 74,435 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.